Publications by authors named "Per Hydbring"

Claim this Profile
C
Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors.
Xun Zhou, Eva Berenger, Yong Shi, Vera Shirokova, Elena Kochetkova, Per Hydbring

EMBO Mol Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses.
Dongfeng Sun, Jie Lu, Wenhua Zhao, Xiaozheng Chen, Changyan Xiao, Per Hydbring

Transl Lung Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study.
Caroline Kamali, Georgios Tsakonas, Per Hydbring, Kenbugul Jatta, Anders Berglund

Transl Lung Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA (ctDNA)-the next generation biomarker in non-small cell lung cancer patients treated with immunotherapy?
Per Hydbring

Transl Lung Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Immune-mediated damage to the heart and lungs in autoimmune diseases.
Lingling Wei, Per Hydbring, Li Long

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Georgios Tsakonas, Vasisht Tadigotla, Sudipto K Chakrabortty, Giuseppe Stragliotto, Dalin Chan, Per Hydbring

Lung Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting gene fusions in non-small cell lung cancer-a ceaseless success story?
Per Hydbring

Transl Lung Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients.
Per Hydbring

Transl Lung Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature.
Georgios Tsakonas, Andreas Koulouris, Dominika Kazmierczak, Johan Botling, Cristian Ortiz-Villalon, Per Hydbring

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients.
Andrey Alexeyenko, Odd Terje Brustugun, Inger Johanne Zwicky Eide, Radosveta Gencheva, Zeinab Kosibaty, Per Hydbring

Transl Lung Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma.
Per Hydbring

Transl Lung Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Qing Wang, Yansu Wang, Xinyu Wang, Yusuke Nakamura, Per Hydbring

Transl Lung Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
Zeinab Kosibaty, Odd Terje Brustugun, Inger Johanne Zwicky Eide, Georgios Tsakonas, Oscar Grundberg, Per Hydbring

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer.
Dominika Kaźmierczak, Inger Johanne Zwicky Eide, Radosveta Gencheva, Yi Lai, Rolf Lewensohn, Per Hydbring

Transl Lung Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concepts and Design of Introducing Synthetic MicroRNAs into Mammalian Cells.
Per Hydbring

Methods Mol Biol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.
Alina Castell, Qinzi Yan, Karin Fawkner, Wesam Bazzar, Fan Zhang, Per Hydbring

Cancer Res Commun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage.
Bo Franzén, Kristina Viktorsson, Caroline Kamali, Eva Darai-Ramqvist, Vitali Grozman, Per Hydbring

Mol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of a Full-Length 3'UTR Reporter System for Identification of Cell-Cycle Regulating MicroRNAs.
Dominika Kaźmierczak, Per Hydbring

Methods Mol Biol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A MicroRNA Gene Panel Predicts the Vaginal Microbiota Composition.
Liqin Cheng, Dominika Kaźmierczak, Johanna Norenhag, Marica Hamsten, Emma Fransson, Per Hydbring

mSystems· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Wesam Bazzar, Matteo Bocci, Eduar Hejll, Vedrana Högqvist Tabor, Per Hydbring

Cell Cycle· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
Georgios Tsakonas, Rolf Lewensohn, Johan Botling, Cristian Ortiz-Villalon, Patrick Micke, Per Hydbring

Eur J Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC.
Yi Lai, Merve Kacal, Maraam Kanony, Iga Stukan, Kenbugul Jatta, Per Hydbring

Biochem Biophys Res Commun· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression.
Per Hydbring, Luigi De Petris, Yanming Zhang, Eva Brandén, Hirsh Koyi

Lung Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation.
Alina Castell, Qinzi Yan, Karin Fawkner, Per Hydbring, Fan Zhang

Sci Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas.
Andre Lima Queiroz, Boxi Zhang, Dawn E Comstock, Yuqing Hao, Matilda Eriksson, Per Hydbring

Biochem Biophys Res Commun· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis